-
1
-
-
84907274369
-
Emerging biomarkers for heart failure: An update
-
Dalzell, J.R.; Cannon, J.A.; Jackson, C.E.; Lang, N.N.; Gardner, R.S. Emerging biomarkers for heart failure: An update. Biomark. Med. 2014, 8, 833–840.
-
(2014)
Biomark. Med
, vol.8
, pp. 833-840
-
-
Dalzell, J.R.1
Cannon, J.A.2
Jackson, C.E.3
Lang, N.N.4
Gardner, R.S.5
-
2
-
-
79961165951
-
Current applications and future needs for biomarkers in pediatric cardiomyopathy and heart failure: Summary from the second international conference on pediatric cardiomyopathy
-
Kantor, P.F.; Rusconi, P.; Lipshultz, S.; Mital, S.; Wilkinson, J.D.; Burch, M. Current applications and future needs for biomarkers in pediatric cardiomyopathy and heart failure: Summary from the second international conference on pediatric cardiomyopathy. Prog. Pediatr. Cardiol. 2011, 32, 11–14.
-
(2011)
Prog. Pediatr. Cardiol
, vol.32
, pp. 11-14
-
-
Kantor, P.F.1
Rusconi, P.2
Lipshultz, S.3
Mital, S.4
Wilkinson, J.D.5
Burch, M.6
-
3
-
-
43549099569
-
Biomarkers in heart failure. N
-
Braunwald, E. Biomarkers in heart failure. N. Engl. J. Med. 2008, 358, 2148–2159.
-
(2008)
Engl. J. Med
, vol.358
, pp. 2148-2159
-
-
Braunwald, E.1
-
4
-
-
12144290445
-
B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-β in primary human cardiac fibroblasts: Fibrosis, myofibroblast conversion, proliferation, and inflammation
-
Kapoun, A.M.; Liang, F.; O’Young, G.; Damm, D.L.; Quon, D.; White, R.T.; Munson, K.; Lam, A.; Schreiner, G.F.; Protter, A.A. B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-β in primary human cardiac fibroblasts: Fibrosis, myofibroblast conversion, proliferation, and inflammation. Circ. Res. 2004, 94, 453–461.
-
(2004)
Circ. Res
, vol.94
, pp. 453-461
-
-
Kapoun, A.M.1
Liang, F.2
O’Young, G.3
Damm, D.L.4
Quon, D.5
White, R.T.6
Munson, K.7
Lam, A.8
Schreiner, G.F.9
Protter, A.A.10
-
5
-
-
0037130155
-
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure
-
Maisel, A.S.; Krishnaswamy, P.; Nowak, R.M.; McCord, J.; Hollander, J.E.; Duc, P.; Omland, T.; Storrow, A.B.; Abraham, W.T.; Wu, A.H, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N. Engl. J. Med. 2002, 347, 161–167.
-
(2002)
N. Engl. J. Med
, vol.347
, pp. 161-167
-
-
Maisel, A.S.1
Krishnaswamy, P.2
Nowak, R.M.3
McCord, J.4
Hollander, J.E.5
Duc, P.6
Omland, T.7
Storrow, A.B.8
Abraham, W.T.9
Wu, A.H.10
-
6
-
-
0034176934
-
Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
-
Troughton, R.W.; Frampton, C.M.; Yandle, T.G.; Espiner, E.A.; Nicholls, M.G.; Richards, A.M. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000, 355, 1126–1130.
-
(2000)
Lancet
, vol.355
, pp. 1126-1130
-
-
Troughton, R.W.1
Frampton, C.M.2
Yandle, T.G.3
Espiner, E.A.4
Nicholls, M.G.5
Richards, A.M.6
-
7
-
-
0042198675
-
B-type natriuretic peptide in cardiovascular disease
-
De Lemos, J.A.; McGuire, D.K.; Drazner, M.H. B-type natriuretic peptide in cardiovascular disease. Lancet 2003, 362, 316–322.
-
(2003)
Lancet
, vol.362
, pp. 316-322
-
-
De Lemos, J.A.1
McGuire, D.K.2
Drazner, M.H.3
-
8
-
-
84907274312
-
Panel of emerging cardiac biomarkers contributes for prognosis rather than diagnosis in chronic heart failure. Biomark
-
Jungbauer, C.G.; Riedlinger, J.; Block, D.; Stadler, S.; Birner, C.; Buesing, M.; König, W.; Riegger, G.; Maier, L.; Luchner, A. Panel of emerging cardiac biomarkers contributes for prognosis rather than diagnosis in chronic heart failure. Biomark. Med. 2014, 8, 777–789.
-
(2014)
Med
, vol.8
, pp. 777-789
-
-
Jungbauer, C.G.1
Riedlinger, J.2
Block, D.3
Stadler, S.4
Birner, C.5
Buesing, M.6
König, W.7
Riegger, G.8
Maier, L.9
Luchner, A.10
-
9
-
-
84924370873
-
Biomarkers and echocardiographic predictors of myocardial dysfunction in patients with hypertension
-
Bielecka-Dabrowa, A.; Michalska-Kasiczak, M.; Gluba, A.; Ahmed, A.; von Healing, S.; Gerdts, E.; Rysz, J.; Banach, M. Biomarkers and echocardiographic predictors of myocardial dysfunction in patients with hypertension. Sci. Rep. 2015, 5, doi:10.1038/srep08916.
-
(2015)
Sci. Rep
, pp. 5
-
-
Bielecka-Dabrowa, A.1
Michalska-Kasiczak, M.2
Gluba, A.3
Ahmed, A.4
Von Healing, S.5
Gerdts, E.6
Rysz, J.7
Banach, M.8
-
10
-
-
84885670488
-
Heart failure biomarkers in patients with dilated cardiomyopathy
-
Bielecka-Dabrowa, A.; von Haehling, S.; Aronow, W.S.; Ahmed, M.I.; Rysz, J.; Banach, M. Heart failure biomarkers in patients with dilated cardiomyopathy. Int. J. Cardiol. 2013, 168, 2404–2410.
-
(2013)
Int. J. Cardiol
, vol.168
, pp. 2404-2410
-
-
Bielecka-Dabrowa, A.1
Von Haehling, S.2
Aronow, W.S.3
Ahmed, M.I.4
Rysz, J.5
Banach, M.6
-
11
-
-
84901271726
-
Effects of hypertension and exercise on cardiac proteome remodelling
-
2014
-
Petriz, B.A.; Franco, O.L. Effects of hypertension and exercise on cardiac proteome remodelling. Biomed. Res. Int. 2014, 2014, 634132.
-
(2014)
Biomed. Res. Int
-
-
Petriz, B.A.1
Franco, O.L.2
-
12
-
-
0142162082
-
-
Available online, (accessed on 8 August 2010)
-
NHS National Institute for Health and Care Excellence: Chronic Heart Failure: Management of Chronic Heart Failure in Adults in Primary and Secondary Care. Available online: http://www.nice.org.uk/guidance/cg108webcite (accessed on 8 August 2010).
-
Management of Chronic Heart Failure in Adults in Primary and Secondary Care
-
-
-
13
-
-
84864493727
-
ESC Committee for Practice Guidelines: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
-
McMurray, J.J.; Adamopoulos, S.; Anker, S.D.; Auricchio, A.; Bohm, M.; Dickstein, K.; Falk, V.; Filippatos, G.; Fonseca, C.; Gomez-Sanchez, M.A, et al. ESC Committee for Practice Guidelines: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 2012, 33, 1787–1847.
-
(2012)
Eur. Heart J
, vol.33
, pp. 1787-1847
-
-
McMurray, J.J.1
Adamopoulos, S.2
Anker, S.D.3
Auricchio, A.4
Bohm, M.5
Dickstein, K.6
Falk, V.7
Filippatos, G.8
Fonseca, C.9
Gomez-Sanchez, M.A.10
-
14
-
-
0141925928
-
Sorting out the evidence on natriuretic peptides
-
McCullough, P.A.; Sandberg, K.R. Sorting out the evidence on natriuretic peptides. Rev. Cardiovasc. Med. 2003, 4, 13–19.
-
(2003)
Rev. Cardiovasc. Med
, vol.4
, pp. 13-19
-
-
McCullough, P.A.1
Sandberg, K.R.2
-
15
-
-
33645501811
-
Anemia in chronic kidney disease: Causes, diagnosis, treatment
-
Nurko, S. Anemia in chronic kidney disease: Causes, diagnosis, treatment. Clevel. Clin. J. Med. 2006, 73, 289–297.
-
(2006)
Clevel. Clin. J. Med
, vol.73
, pp. 289-297
-
-
Nurko, S.1
-
16
-
-
0042809588
-
N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease
-
James, S.K.; Lindahl, B.; Siegbahn, A.; Stridsberg, M.; Venge, P.; Armstrong, P.; Barnathan, E.S.; Califf, R.; Topol, E.J.; Simoons, M.L, et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease. Circulation 2003, 108, 275–281.
-
(2003)
Circulation
, vol.108
, pp. 275-281
-
-
James, S.K.1
Lindahl, B.2
Siegbahn, A.3
Stridsberg, M.4
Venge, P.5
Armstrong, P.6
Barnathan, E.S.7
Califf, R.8
Topol, E.J.9
Simoons, M.L.10
-
17
-
-
0037019567
-
Plasma brain natriuretic peptide concentration: Impact of age and gender
-
Redfield, M.M.; Rodeheffer, R.J.; Jacobsen, S.J.; Mahoney, D.W.; Bailey, K.K.; Burnett, J.C., Jr. Plasma brain natriuretic peptide concentration: Impact of age and gender. J. Am. Coll. Cardiol. 2002, 40, 976–982.
-
(2002)
J. Am. Coll. Cardiol
, vol.40
, pp. 976-982
-
-
Redfield, M.M.1
Rodeheffer, R.J.2
Jacobsen, S.J.3
Mahoney, D.W.4
Bailey, K.K.5
Burnett, J.C.6
-
18
-
-
84871326314
-
Influencing factors for the plasma concentration of N-terminal brain natriuretic peptide precursor in patients with heart failure due to various heart diseases
-
Wei, B.Q.; Zhang, J.; Yang, Y.J.; Zhang, Y.H.; Huang, X.H.; Yu, L.T.; Zhou, Q.; Tan, H.Q.; Yang, Y.M.; Wang, G.G, et al. Influencing factors for the plasma concentration of N-terminal brain natriuretic peptide precursor in patients with heart failure due to various heart diseases. Zhonghua Yi Xue Za Zhi 2011, 91, 2683–2687.
-
(2011)
Zhonghua Yi Xue Za Zhi
, vol.91
, pp. 2683-2687
-
-
Wei, B.Q.1
Zhang, J.2
Yang, Y.J.3
Zhang, Y.H.4
Huang, X.H.5
Yu, L.T.6
Zhou, Q.7
Tan, H.Q.8
Yang, Y.M.9
Wang, G.G.10
-
19
-
-
31444448021
-
Controversies in ventricular remodelling
-
Opie, L.H.; Commerford, P.J.; Gersh, B.J. Controversies in ventricular remodelling. Lancet 2006, 367, 356–367.
-
(2006)
Lancet
, vol.367
, pp. 356-367
-
-
Opie, L.H.1
Commerford, P.J.2
Gersh, B.J.3
-
20
-
-
79954429830
-
Transforming growth factor
-
Behnes, M.; Hoffmann, U.; Lang, S.; Weiss, C.; Ahmad-Nejad, P.; Neumaier, M.; Borggrefe, M.; Brueckmann, M. Transforming growth factor β1 (TGF-β1) in atrial fibrillation and acute congestive heart failure. Clin. Res. Cardiol. 2011, 100, 335–342.
-
(2011)
Clin. Res. Cardiol
, vol.100
, pp. 335-342
-
-
Behnes, M.1
Hoffmann, U.2
Lang, S.3
Weiss, C.4
Ahmad-Nejad, P.5
Neumaier, M.6
Borggrefe, M.7
Brueckmann, M.8
-
21
-
-
77954083241
-
Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target
-
Dobrev, D. Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target. Naunyn Schmiedebergs Arch. Pharmacol. 2010, 381, 195–206.
-
(2010)
Naunyn Schmiedebergs Arch. Pharmacol
, vol.381
, pp. 195-206
-
-
Dobrev, D.1
-
22
-
-
0034881463
-
Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart
-
Ogawa, Y.; Tamura, N.; Chusho, H.; Nakao, K. Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart. Can. J. Physiol. Pharmacol. 2001, 79, 723–729.
-
(2001)
Can. J. Physiol. Pharmacol
, vol.79
, pp. 723-729
-
-
Ogawa, Y.1
Tamura, N.2
Chusho, H.3
Nakao, K.4
-
23
-
-
41149122223
-
Atrial natriuretic peptide inhibits transforming growth factor β-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts
-
Li, P.; Wang, D.; Lucas, J.; Oparil, S.; Xing, D.; Cao, X.; Novak, L.; Renfrow, M.B.; Chen, Y.F. Atrial natriuretic peptide inhibits transforming growth factor β-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts. Circ. Res. 2008, 102, 185–192.
-
(2008)
Circ. Res
, vol.102
, pp. 185-192
-
-
Li, P.1
Wang, D.2
Lucas, J.3
Oparil, S.4
Xing, D.5
Cao, X.6
Novak, L.7
Renfrow, M.B.8
Chen, Y.F.9
-
24
-
-
84855280828
-
Cardiotrophin-1 plasma levels are increased in patients with diastolic heart failure
-
Celik, A.; Sahin, S.; Koc, F.; Karayakali, M.; Sahin, M.; Benli, I.; Kadi, H.; Burucu, T.; Ceyhan, K. Cardiotrophin-1 plasma levels are increased in patients with diastolic heart failure. Med. Sci. Monit. 2012, 18, CR25–CR31.
-
(2012)
Med. Sci. Monit
, vol.18
, pp. CR25-CR31
-
-
Celik, A.1
Sahin, S.2
Koc, F.3
Karayakali, M.4
Sahin, M.5
Benli, I.6
Kadi, H.7
Burucu, T.8
Ceyhan, K.9
-
25
-
-
84894466867
-
Association of cardiotrophin-1 with myocardial fibrosis in hypertensive patients with heart failure
-
López, B.; González, A.; Querejeta, R.; Larman, M.; Rábago, G.; Díez, J. Association of cardiotrophin-1 with myocardial fibrosis in hypertensive patients with heart failure. Hypertension 2014, 63, 483–489.
-
(2014)
Hypertension
, vol.63
, pp. 483-489
-
-
López, B.1
González, A.2
Querejeta, R.3
Larman, M.4
Rábago, G.5
Díez, J.6
-
26
-
-
84884200646
-
Association of cardiotrophin-1 with left ventricular systolic properties in asymptomatic hypertensive patients
-
Ravassa, S.; Beloqui, O.; Varo, N.; Barba, J.; López, B.; Beaumont, J.; Zalba, G.; Díez, J.; González, A. Association of cardiotrophin-1 with left ventricular systolic properties in asymptomatic hypertensive patients. J. Hypertens. 2013, 31, 587–594.
-
(2013)
J. Hypertens
, vol.31
, pp. 587-594
-
-
Ravassa, S.1
Beloqui, O.2
Varo, N.3
Barba, J.4
López, B.5
Beaumont, J.6
Zalba, G.7
Díez, J.8
González, A.9
-
27
-
-
84907963375
-
Plasma cardiotrophin-1 levels are associated with hypertensive heart disease: A meta-analysis
-
Song, K.; Wang, S.; Huang, B.; Luciano, A.; Srivastava, R.; Mani, A. Plasma cardiotrophin-1 levels are associated with hypertensive heart disease: A meta-analysis. J. Clin. Hypertens. 2014, 16, 686–692.
-
(2014)
J. Clin. Hypertens
, vol.16
, pp. 686-692
-
-
Song, K.1
Wang, S.2
Huang, B.3
Luciano, A.4
Srivastava, R.5
Mani, A.6
-
29
-
-
11844300754
-
Cystatin C and mortality in elderly persons with heart failure
-
Shipak, M.G.; Sarnak, M.J.; Katz, R.; Fried, L.; Seliger, S.; Newman, A.; Siscovick, D.; Stehman-Breen, C. Cystatin C and mortality in elderly persons with heart failure. J. Am. Coll. Cardiol. 2005, 45, 268–271.
-
(2005)
J. Am. Coll. Cardiol
, vol.45
, pp. 268-271
-
-
Shipak, M.G.1
Sarnak, M.J.2
Katz, R.3
Fried, L.4
Seliger, S.5
Newman, A.6
Siscovick, D.7
Stehman-Breen, C.8
-
30
-
-
82255192295
-
Levels are associated with the prognosis of systolic heart failure patients
-
Gao, C.; Zhong, L.; Gao, Y.; Li, X.; Zhang, M.; Wei, S. Cystatin C levels are associated with the prognosis of systolic heart failure patients. Arch. Cardiovasc. Dis. 2011, 104, 565–571.
-
(2011)
Arch. Cardiovasc. Dis
, vol.104
, pp. 565-571
-
-
Gao, C.1
Zhong, L.2
Gao, Y.3
Li, X.4
Zhang, M.5
Wei, S.6
Cystatin, C.7
-
31
-
-
84885787769
-
Concentration as an independent marker for hypertensive left ventricular hypertrophy
-
Li, X.; Zhu, H.; Li, P.; Xin, Q.; Liu, J.; Zhang, W.; Xing, Y.H.; Xue, H. Serum cystatin C concentration as an independent marker for hypertensive left ventricular hypertrophy. J. Geriatr. Cardiol. 2013, 10, 286–290.
-
(2013)
J. Geriatr. Cardiol
, vol.10
, pp. 286-290
-
-
Li, X.1
Zhu, H.2
Li, P.3
Xin, Q.4
Liu, J.5
Zhang, W.6
Xing, Y.H.7
Xue, H.8
Serum Cystatin, C.9
-
32
-
-
67649394229
-
Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic peptide and cardiac troponin T in patients with acute heart failure
-
Manzano-Fernández, S.; Boronat-Garcia, M.; Albaladejo-Otón, M.D.; Pastor, P.; Garrido, I.P.; Pastor-Pérez, F.J.; Martínez-Hernández, P.; Valdés, M.; Pascual-Figal, D.A. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic peptide and cardiac troponin T in patients with acute heart failure. Am. J. Cardiol. 2009, 103, 1753–1759.
-
(2009)
Am. J. Cardiol
, vol.103
, pp. 1753-1759
-
-
Manzano-Fernández, S.1
Boronat-Garcia, M.2
Albaladejo-Otón, M.D.3
Pastor, P.4
Garrido, I.P.5
Pastor-Pérez, F.J.6
Martínez-Hernández, P.7
Valdés, M.8
Pascual-Figal, D.A.9
-
33
-
-
38349103706
-
Cystatin C concentration as a predictor of systolic and diastolic heart failure
-
Moran, A.; Katz, R.; Smith, N.L.; Fried, L.F.; Sarnak, M.J.; Seliger, S.L.; Psaty, B.; Siscovick, D.S.; Gottdiener, J.S.; Shlipak, M.G. Cystatin C concentration as a predictor of systolic and diastolic heart failure. J. Card. Fail. 2008, 14, 19–26.
-
(2008)
J. Card. Fail
, vol.14
, pp. 19-26
-
-
Moran, A.1
Katz, R.2
Smith, N.L.3
Fried, L.F.4
Sarnak, M.J.5
Seliger, S.L.6
Psaty, B.7
Siscovick, D.S.8
Gottdiener, J.S.9
Shlipak, M.G.10
-
35
-
-
0016998022
-
Grading of angina pectoris
-
Campeau, L. Grading of angina pectoris. Circulation 1976, 54, 522–523.
-
(1976)
Circulation
, vol.54
, pp. 522-523
-
-
Campeau, L.1
-
36
-
-
0033574249
-
A more accurate accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation
-
Modification of Diet in Renal Disease Study Group. A more accurate accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann. Intern. Med. 1999, 130, 461–470.
-
(1999)
Ann. Intern. Med
, vol.130
, pp. 461-470
-
-
-
37
-
-
32944459711
-
Recommendations for chamber quantification
-
Lang, R.M.; Bierig, M.; Devereux, R.B.; Flachskampf, F.A.; Foster, E.; Pellikka, P.A.; Picard, M.H.; Roman, M.J.; Seward, J.; Shanewise, J, et al. Recommendations for chamber quantification. Eur. J. Echocardiogr. 2006, 7, 79–108.
-
(2006)
Eur. J. Echocardiogr
, vol.7
, pp. 79-108
-
-
Lang, R.M.1
Bierig, M.2
Devereux, R.B.3
Flachskampf, F.A.4
Foster, E.5
Pellikka, P.A.6
Picard, M.H.7
Roman, M.J.8
Seward, J.9
Shanewise, J.10
-
38
-
-
38749137358
-
Statistical evaluation of prognostic versus diagnostic models: Beyond the ROC curve
-
Cook, N.R. Statistical evaluation of prognostic versus diagnostic models: Beyond the ROC curve. Clin. Chem. 2008, 54, 17–23.
-
(2008)
Clin. Chem
, vol.54
, pp. 17-23
-
-
Cook, N.R.1
-
39
-
-
79959716798
-
PredictABEL: An R package for the assessment of risk prediction models
-
Kundu, S.; Aulchenko, Y.S.; van Duijn, C.M.; Janssens, A.C.J.W. PredictABEL: An R package for the assessment of risk prediction models. Eur. J. Epidemiol. 2011, 26, 261–264.
-
(2011)
Eur. J. Epidemiol
, vol.26
, pp. 261-264
-
-
Kundu, S.1
Aulchenko, Y.S.2
Van Duijn, C.M.3
Janssens, A.4
-
40
-
-
38849091997
-
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
-
Pencina, M.J.; D’Agostino, R.B., Sr.; D’Agostino, R.B., Jr.; Vasan, R.S. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat. Med. 2008, 27, 157–172.
-
(2008)
Stat. Med
, vol.27
, pp. 157-172
-
-
Pencina, M.J.1
D’Agostino, R.B.2
D’Agostino, R.B.3
Vasan, R.S.4
-
41
-
-
78649477601
-
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
-
Pencina, M.J.; D’Agostino, R.B., Sr.; Steyerberg, E.W. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat. Med. 2011, 30, 11–21.
-
(2011)
Stat. Med
, vol.30
, pp. 11-21
-
-
Pencina, M.J.1
D’Agostino, R.B.2
Steyerberg, E.W.3
|